Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Aging Well Together - 'Getting to Know You Better': Characterization of Health FACTors in People Advancing in AGE (BVE-FACTAGE)

11 de junio de 2026 actualizado por: Centre Hospitalier Universitaire de Nice

BVE-FACTAGE: Aging Well Together - 'Getting to Know You Better': Characterization of Health FACTors in People Advancing in AGE

In order to implement effective actions to prevent the loss of autonomy in older adults, which has become a major issue, a crucial first step is to identify the conditions that influence it. Current approaches to health increasingly rely on a comprehensive and multidisciplinary vision, in line with so-called "socio-ecological" approaches, which argue that health is influenced by a wide range of interacting factors. However, these interdependencies and interactions are still poorly understood. It therefore seems necessary to move beyond the isolated analyses of risk factors carried out to date and adopt a holistic/systemic vision by examining both individual and environmental factors, as well as their interactions, which together can contribute to functional decline or the development of pathologies in older adults and those aging.

The aim of this study is to identify the relationships between intrapersonal and environmental factors, and their cumulative, moderating, and mediating effects on the health of older adults and those experiencing aging.

To this end, participants will be asked to complete a series of questionnaires and perform tests on various health-related dimensions. The evaluation criteria are: health, autonomy and quality of life, individual factors (health practices (e.g., physical activity), psychological characteristics (e.g., personal beliefs), socioeconomic status, etc.) and environmental factors (accessibility, living environment).

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Estimado)

4500

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Olivier GUERIN, Pr
  • Número de teléfono: +33 0492034194
  • Correo electrónico: guerin.o@chu-nice.fr

Copia de seguridad de contactos de estudio

Ubicaciones de estudio

      • Nice, Francia
        • CHU de Nice - Hopital de Cimiez
        • Investigador principal:
          • Olivier GUERIN, Professor
        • Contacto:
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria:

  • Age 55 or older
  • Affiliation with, or beneficiary of, a social security system
  • No objection to the study

Exclusion Criteria:

  • Individuals protected by law
  • unable to participate in a clinical trial
  • deprived of liberty

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: FACTAGE
Questionnaires and tests on health behaviors and health

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Autonomy
Periodo de tiempo: at baseline and at 6 months and at 12 months

Autonomy is assessed using the Instrumental Activities of Daily Living (IADL) Scale of Lawton.

The scale comprises 8 items. The total score ranges from 0 to 8, with a higher score being better.

at baseline and at 6 months and at 12 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Care consumption, health behavior and psycho-socio-environmental characteristics
Periodo de tiempo: at baseline and at 6 and 12 months
The evaluation criteria will be, on the one hand, the same individual and environmental factors (e.g., personal beliefs, socio-economic status, accessibility, physical activity, diet) mentioned previously for the main objective, and on the other hand, the consumption of care (number and types of care).
at baseline and at 6 and 12 months
Measure Quality of life
Periodo de tiempo: at baseline and at 6 months and at 12 months

Quality of life is assessed using the EuroQol at 5 dimensions (EQ-5D) questionnaire.

The scale comprises 5 items. Each item is scored from 1 "no problem" to 3 "severe problem". The total score ranges from 5 to 15 with higher score indicating a worse outcome.

at baseline and at 6 months and at 12 months
Physical functional force (physical measure)
Periodo de tiempo: at baseline and at 6 months and at 12 months
: Physical functional force is assessed using the 5 sit-to-stand test wich consists of asking the participant to stand up and sit down from a chair 5 times as quickly as possible. The outcome is the time taken to complete the test, and the unit of measurement is seconds.
at baseline and at 6 months and at 12 months
Sarcopenia (physical measure)
Periodo de tiempo: at baseline and at 6 months and at 12 months
Sarcopenia is assessed using the SARC-F questionnaire comprising 5 items assessing force, walk difficulties, stand up capacities, climb stairs capacities and fall. Each item is scored from 0 to 2. The total score ranges from 0 to 10 with higher score indicating a worse outcome.
at baseline and at 6 months and at 12 months
Daily Physical activity Practice (physical behavioral lifestyle measure
Periodo de tiempo: at baseline and at 6 months and at 12 months
Daily Physical activity Practice is assessed using the Marshall questionnaire comprising 2 items. The total score ranges from 0 to 8. A higher score means a higher level of physical activity. The cut of 4 correspond to "sufficiently active".
at baseline and at 6 months and at 12 months
Subjective cognitive complaint (cognitive measure)
Periodo de tiempo: at baseline and at 6 and 12 months
Subjective cognitive complaint is assessed using items from the ICOPE cohort, regarding the presence and worsening (yes/no) of memory and orientation problems
at baseline and at 6 and 12 months
Body Mass Index (nutritional measure)
Periodo de tiempo: at baseline, 6 months later and 12 months
Body Mass Index corresponds to corresponds to weight (kg) divided by height (m) squared. The unit is kg/m2.
at baseline, 6 months later and 12 months
Memory (cognitive measure)
Periodo de tiempo: at baseline, 6 months later and 12 months
Memory is assessed using a 3-word recall test. Recalling a word is worth 1 point. A higher score is better.
at baseline, 6 months later and 12 months
Cognitive attention (cognitive measure)
Periodo de tiempo: at baseline, 6 months later and 12 months
Cognitive attention is assessed consisting of asking to change the focus of attention. Fewer errors result in a better score
at baseline, 6 months later and 12 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de septiembre de 2026

Finalización primaria (Estimado)

1 de septiembre de 2031

Finalización del estudio (Estimado)

1 de septiembre de 2031

Fechas de registro del estudio

Enviado por primera vez

13 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

11 de junio de 2026

Publicado por primera vez (Actual)

16 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

16 de junio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

11 de junio de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir